BioLineRx Ltd. to Present at the Oppenheimer 14th Annual Israeli Conference on May 12th
5/9/2013 7:44:34 AM
More...
|
BioLineRx Ltd. Reports First Quarter 2013 Results
5/7/2013 8:09:50 AM
More...
|
BioLineRx Ltd.'s BL-7010, for the Treatment of Celiac, to be Presented at Two Leading Conferences
5/2/2013 11:40:33 AM
More...
|
BioLineRx Ltd. to Report First Quarter 2013 Results on May 7, 2013
4/30/2013 6:47:53 AM
More...
|
BioLineRx Ltd. to Present at the 12th Annual Needham Healthcare Conference in New York on April 30, 2013
4/18/2013 7:24:17 AM
More...
|
BioLineRx Ltd. Says CLARITY Trial of BL-1020 Did Not Meet Primary Efficacy Endpoint, to Discontinue Study
3/20/2013 7:35:54 AM
More...
|
BioLineRx Ltd. Reports Year End 2012 Financial Results
3/12/2013 6:22:01 AM
More...
|
BioLineRx Ltd.'s EDP-14, for Treatment of Severe and Persistent Asthma, to Enter the Company's Main Therapeutic Pipeline as BL-9010
2/28/2013 9:55:33 AM
More...
|
BioLineRx Ltd. to Report Fourth Quarter and Year End 2012 Results on March 12, 2013
2/26/2013 6:57:26 AM
More...
|
BioLineRx Ltd. Announces Closing of $8 Million Offering of American Depositary Shares
2/13/2013 11:08:43 AM
More...
|
|